U.S. Markets open in 4 hrs 3 mins

INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – AMTD, TIF, MDCO, PGNX

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

TD Ameritrade Holding Corporation (AMTD)
The investigation concerns whether TD Ameritrade and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of TD Ameritrade to The Charles Schwab Corporation for 1.0837 Charles Schwab shares for each TD Ameritrade share. If you are a TD Ameritrade shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/td-ameritrade-holding-corporation-amtd-stock-merger-charles-schwab/.

Tiffany & Co. (TIF
The investigation concerns whether Tiffany and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Tiffany to LVMH Moët Hennessy Louis Vuitton SE for $135.00 per share. If you are a Tiffany shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/tiffany-co-tif-stock-merger-lvmh/.

The Medicines Company (MDCO
The investigation concerns whether The Medicines Company and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of The Medicines Company to Novartis AG for $85.00 per share. If you are a shareholder of The Medicines Company and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/the-medicines-company-mdco-stock-merger-novartis-ag/.

Progenics Pharmaceuticals, Inc. (PGNX
The investigation concerns whether Progenics and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Progenics to Lantheus Holdings, Inc. If you are a Progenics shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/progenics-pharmaceuticals-inc-pgnx-stock-merger-lantheus/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com